معرفی
Natasha Balkcom is a Research Associate 2 in the Department of Internal Medicine at Yale University's Yale School of Medicine. She holds a BS in Biological Sciences from the University of Connecticut. Her research focuses on cardiology, nephrology, and infectious diseases, with a particular emphasis on heart failure therapies, diuretic mechanisms, and SARS-CoV-2 antibody dynamics. She collaborates with prominent researchers such as Albert Ko and Akiko Iwasaki on projects addressing diuretic efficacy, viral outbreak response, and clinical outcomes of severe COVID-19 cases.
Her work spans clinical trials, pharmacological studies, and AI-driven patient triage platforms. Notable contributions include investigations into the mechanistic differences between torsemide and furosemide in heart failure patients and analyses of antibody responses in severe SARS-CoV-2 infections. Her publications reflect interdisciplinary approaches bridging clinical medicine, immunology, and computational modeling.
Collaborations extend to institutions like the IMPACC study group, focusing on cohort analyses of hospitalized patients. Despite her active research profile, no formal awards or student advisement roles are listed.